Investing
450 Articles
Jon OggWe are knee-deep in corporate earnings reports and markets are surging to new all-time highs. Investors and traders alike…
ThinkstockWith yields on 10-year Treasury bonds up nearly 1.5% since early May and briefly touching 3.0% last week, the impact…
ThinkstockMerck & Co. Inc. (NYSE: MRK) is seeing one more drug drive off the patent cliff. News was released on…
August 5, 2013: U.S. equity markets opened lower this morning, lacking any major news of interest from around the globe.…
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Monday, August 5, 2013.…
Jon OggInvestors and traders are often on the hunt for new research ideas that will generate higher income or more…
ThinkstockTypically, specialty pharmaceutical companies either provide generic versions of former top-selling branded drugs or they may focus on drugs that…
Investors and traders are often on the hunt for fresh research ideas that will lead to higher income or more…
The research team at UBS A.G. (NYSE: UBS) has released what Wall Street calls a Q-GARP list, which is simply…
ThinkstockOver the past five weeks, the 10-year Treasury bond yield has increased by over one-half of one percent from 1.66%…
Investors and traders frequently search for fresh research ideas that will lead to higher income or more profits. 24/7 Wall…
ThinkstockTotal return is always the name of the game when it comes to investing success. Stocks that pay dividends on…
ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating…
As the stock market keeps hitting new highs, the spreads of high-yield bonds and junk bonds has been narrowing and…
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Abaxis Inc.…
Our top personal finance-related articles today. Your wallet will thank you later.